ABBV - AbbVie plans to offer senior notes to fund Immunogen Cerevel deals
2024-02-21 13:26:32 ET
More on AbbVie
- AbbVie Q4: Now Isn't The Time To Buy My Largest Big Pharma Holding
- AbbVie: Game Changer
- AbbVie Q4 Review: Stock Remains A Buy, Encouraged By Skyrizi And Rinvoq
- AbbVie names Robert A. Michael as CEO and Richard A. Gonzalez as Executive Chairman
- Cerevel, AbbVie get FTC Second Requests for more merger info